Company Dimension Therapeutics Inc
Equities
US25433V1052
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Kassberg
PSD | President | 63 | 17-11-06 |
Stephanie Haller
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Karah Parschauer
BRD | Director/Board Member | 46 | 17-11-06 |
Shalini Sharp
TRE | Treasurer | 49 | 17-11-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karah Parschauer
BRD | Director/Board Member | 46 | 17-11-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,371,591 | 25,052,628 ( 98.74 %) | 0 | 98.74 % |
Company contact information
Dimension Therapeutics, Inc.
840 Memorial Drive 4th floor
02139-3203, Cambridge
+617-401-0011
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |